• 短篇与病例报告 • 上一篇    下一篇

前列腺导管腺癌一例报告

解春军   

  1. 天津市蓟县中医医院
  • 收稿日期:2011-01-17 修回日期:2011-05-12 出版日期:2011-09-15 发布日期:2011-09-15
  • 通讯作者: 解春军

Ductal Adenocarcinoma of the Prostate(a case report and literature review)

Xie Chun Jun ZHANG gang WU chang li   

  • Received:2011-01-17 Revised:2011-05-12 Published:2011-09-15 Online:2011-09-15
  • Contact: Xie Chun Jun ZHANG gang WU chang li

摘要: 【摘要】 目的 探讨前列腺导管腺癌的临床特征及诊疗。方法 总结1例前列腺导管腺癌患者的临床。男性, 82岁,主因“尿频、尿急7年,加重3月”入院。血清总PSA为2.38 ng?ml-1,直肠指诊(DRE)未见异常,经直肠B超引导下前列腺穿刺病理活检提示:右中PIN 1级,其余部位前列腺增生伴炎症,实施经尿道前列腺电切术(TURP)。结果 病理报告:前列腺导管腺癌,Gleason分级5\3(SUM =8分)。免疫组化染色PSA (+),前列腺酸性磷酸酶(PAP)(+),低分子角蛋白(CKAE)+,高分子角蛋白(CKHW) +,雄激素受体(AR)(-)。患者术后恢复良好,行雄激素阻断内分泌治疗。随访12个月,B超及直肠指诊(DRE)检查未见异常。结论 前列腺导管腺癌在前列腺癌中罕见,难于早期诊断,确诊主要依赖免疫组织化学检查,治疗上多采用TURP+激素和/或放疗为主。

关键词: 前列肿瘤, 导管腺癌, 诊断, 治疗

Abstract: 【Abstract 】 Objective To reported a case of Ductal Adenocarcinoma of the Prostate g and the relevant literature was reviewed to investigate the diagnosis and treatment of this disease.evaluate the clinical and pathological characteristics treatment ,prognosis of ductal adenocarcinoma of the Prostate.Methods A 82-year-old male suffered from "frequency, urgency, 7 years, increased for 3 months" misdiagnosis of patients. His serum prostatic specific antigen(PSA)level was 2.38 ng?ml-1.transurethral prostatic resection,(TURP) was performed on him.Results The postoperative pathology showed a primary Ductal Adenocarcinoma.Gleason score was 8.With immunohistochemical staining,the tumor cells were positive for PSA ,PAP (prostatic acid phosphatase) ,CKAE and CKHW,but negative for androgen receptor.Postoperatively,the patient recovered fairishly but long-term effects need further follow-up.Conclusion Ductal Adenocarcinoma of the Prostate is a clinically rare subtype of prostate cancer and difficult to be found in early stage.The diagnosis depends on histopathologic and immunohistochemical studies.Radical prostatectomy is recommended for this disease.

Key words: prostate cancer, ductal adenocarcinoma, diagnosis, treatment.